Formamide Market Size To Reach $2.31 Billion By 2033

Formamide Market Growth & Trends

The global formamide market size is anticipated to reach USD 2.31 billion by 2033 and is projected to grow at a CAGR of 3.5% during the forecast period, according to a new report by Grand View Research, Inc. The market is driven by sustained demand from the pharmaceutical and agrochemical industries, where it is widely used as a solvent and intermediate in active ingredient synthesis. Expanding API manufacturing, rising agricultural chemical consumption, and growing industrial processing activities in emerging economies are supporting consistent volume uptake. The increasing requirements for high-purity solvents in regulated applications further reinforce market demand.

Growth opportunities are emerging from the expansion of pharma-grade formamide, supported by rising investments in drug development, biotechnology, and specialty chemical production. Supply chain diversification and localized manufacturing initiatives in North America and Europe also create room for regional capacity expansion. Furthermore, the development of value-added and customized grades for niche industrial and personal care applications offers margin-enhancement potential for manufacturers.

The market faces challenges related to environmental regulations, occupational safety concerns, and compliance costs associated with chemical handling and emissions. Feedstock price volatility and dependence on concentrated production hubs, particularly in Asia, may impact supply stability and margins. The availability of alternative solvents in certain industrial applications could limit long-term demand expansion.

The industrial grade segment dominated the global formamide industry with a 62.2% revenue share in 2025 primarily due to its extensive use in high-volume applications such as agrochemical manufacturing, textile and leather processing, and general chemical synthesis. Its lower production cost, broader purity tolerance, and suitability for large-scale industrial operations make it the preferred choice across price-sensitive end use sectors. Strong demand from emerging manufacturing economies and stable consumption across mature industrial markets further reinforced its volume-driven revenue leadership.

The pharmaceuticals segment captured the largest revenue share of 31.2% in 2025 due to the critical role of formamide as a high-purity solvent and reaction intermediate in the synthesis of active pharmaceutical ingredients (APIs) and specialty drug compounds. Growing global drug production, increasing R&D investments, and stringent regulatory requirements for reliable and high-quality chemical inputs have sustained strong demand within this segment. The expansion of pharmaceutical manufacturing capacity in emerging markets further strengthened its revenue contribution.

North America held the largest revenue share of 32.3% in 2025 driven by its well-established pharmaceutical manufacturing base, advanced chemical processing infrastructure, and strong demand for high-purity solvents in regulated industries. The region benefits from robust R&D activity, a mature agrochemical sector, and stable industrial consumption, particularly in the United States. The stringent quality standards and supply chain reliability requirements favor established producers, reinforcing the region’s revenue leadership in the global market.

 Request a free sample copy or view report summary: Formamide Market Report

Formamide Market Report Highlights

• The pharma grade segment is expected to grow at the fastest CAGR of 3.7% from 2026 to 2033, driven by rising global pharmaceutical production, increasing investments in drug development, and expanding API manufacturing capacity across emerging markets. Growing regulatory emphasis on high-purity, compliant solvents in drug synthesis further supports demand for pharma-grade formamide. The shift toward complex and specialty formulations in both small-molecule and advanced therapeutics is expected to sustain higher value-driven growth relative to industrial-grade products.

• The cosmetics & personal care segment is expected to grow at the second fastest CAGR of 3.7% from 2026 to 2033, supported by rising global demand for premium beauty and personal care products, particularly in emerging economies. Increasing formulation complexity and the use of specialty solvents in hair care and skincare applications are driving incremental consumption of high-quality chemical ingredients. The growing consumer spending, product innovation, and expansion of organized retail channels are expected to sustain steady demand growth within this segment.

• The US dominated the North American formamide industry with a 76.7% revenue share in 2025, driven by its large-scale pharmaceutical manufacturing base, advanced chemical production infrastructure, and strong demand from agrochemical and specialty industrial sectors. The country’s robust R&D ecosystem, presence of major chemical producers, and stringent regulatory standards supporting high-purity solvent usage further reinforced domestic consumption. The well-established supply chains and ongoing reshoring initiatives in API manufacturing strengthened the U.S. market’s leadership within the region.

• Key industry participants include Merck KGaA, BASF SE, Eastman Chemical Company, MITSUBISHI GAS CHEMICAL COMPANY, INC, Anhui Royal Chemical Co., Ltd., Spectrum Chemical, Thermo Fisher Scientific Inc., Central Drug House, Muby Chemicals, and Shijiazhuang Sincere Chemicals Co., Ltd.

• The agrochemicals segment held the second largest revenue share of 24.3% in 2025 due to the extensive use of formamide as an intermediate in the synthesis of pesticides, herbicides, and crop protection chemicals. Rising global food demand, increasing agricultural productivity requirements, and expansion of commercial farming practices, particularly in emerging economies, have sustained strong consumption levels. The continued innovation in crop protection formulations and stable demand from large agricultural markets reinforced the segment’s significant revenue contribution.

Formamide Market Segmentation

Grand View Research has segmented the global formamide market based on grade, application, and region:

Formamide Grade Outlook (Volume, Kilotons; Revenue, USD Million, 2021 - 2033)

• Industrial Grade

• Pharma Grade

Formamide Application Outlook (Volume, Kilotons; Revenue, USD Million, 2021 - 2033)

• Pharmaceuticals

• Cosmetics & Personal Care

• Agrochemicals

• Textiles & Leather

• Other Applications

Formamide Regional Outlook (Volume, Kilotons; Revenue, USD Million, 2021 - 2033)

• North America

  • U.S.

  • Canda

  • Mexico

• Europe

  • Germany

  • UK

  • France

  • Italy

  • Spain

• Asia Pacific

  • China

  • India

  • Japan

  • South Korea

• Latin America

  • Brazil

  • Argentina

• Middle East & Africa

  • Saudi Arabia

  • South Africa

List of Key Players in the Formamide Market

• Eastman Chemical Company

• MITSUBISHI GAS CHEMICAL COMPANY, INC

• Anhui Royal Chemical Co., Ltd.

• Spectrum Chemical

• Thermo Fisher Scientific Inc.

• BASF SE

• Central Drug House

• Merck KGaA

• Muby Chemicals

• Shijiazhuang Sincere Chemicals Co., Ltd.